| Literature DB >> 34997697 |
William W Davis1,2, Joshua A Mott1,2, Sonja J Olsen1.
Abstract
BACKGROUND: Low global influenza circulation was reported during the coronavirus-19 pandemic. We explored relationships between non-pharmaceutical interventions (NPIs) and influenza in tropical Asian countries.Entities:
Keywords: Asia; COVID-19; NPIs; non-pharmaceutical interventions; seasonal influenza
Mesh:
Year: 2022 PMID: 34997697 PMCID: PMC8983905 DOI: 10.1111/irv.12953
Source DB: PubMed Journal: Influenza Other Respir Viruses ISSN: 1750-2640 Impact factor: 4.380
Parameters of typical and 2020/21 influenza seasons, by country
| Start week | Peak week | End week | Season length (weeks) | Average percent positivity across season | Peak intensity (% positive) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Country | Year | Typical season | During pandemic | Typical season | During pandemic | Typical season | During pandemic | Typical season | During pandemic | Typical season | During pandemic |
| Typical season | During pandemic |
|
| Bangladesh | 2020 | 11 | 35 | 23 | 38 | 39 | 42 | 28 | 7 | 20.3 | 16.5 | 0.7 | 45.4 | 23.1 | <0.01 |
| Indonesia | 2020 | 41 | 35 | 43 | 35 | 45 | 35 | 4 | 0 | 32.9 | 0 | 0.08 | 23.3 | 20.5 | 0.18 |
| Indonesia | 2021 | 1 | 7 | 17 | 16 | 0 | 21.1 | 0 | <0.001 | 44.8 | 0 | ||||
| India | 2020 | 29 | 36 | 44 | 15 | 0 | 16.1 | 2 | 0.002 | 17.9 | 0.0 | ||||
| India | 2021 | 4 | 9 | 18 | 14 | 0 | 14.8 | 0.8 | <0.001 | 26.8 | 0.0 | ||||
| Cambodia | 2020 | 20 | 31 | 30 | 38 | 40 | 44 | 20 | 13 | 31.5 | 36.9 | 0.44 | 54.8 | 56.9 | 0.65 |
| Cambodia | 2020 | 40 | 42 | 47 | 7 | 0 | 23.9 | 24.1 | 0.96 | 29.8 | 0.0 | ||||
| Lao PDR | 2020 | 31 | 48 | 39 | 50 | 49 | 51 | 18 | 3 | 15.1 | 14.9 | 0.78 | 32.6 | 15.5 | 0.02 |
| Lao PDR | 2021 | 51 | 5 | 4 | 8 | 11 | 11 | 12 | 6 | 19.4 | 13.1 | 0.1 | 17.3 | 17.9 | 0.04 |
| Malaysia | 2020 | 33 | 43 | 45 | 12 | 0 | 8.2 | 0.1 | <0.001 | 23.2 | 0.0 | ||||
| Malaysia | 2021 | 6 | 16 | 27 | 21 | 0 | 10.2 | 0.1 | <0.001 | 14.9 | 0.6 | ||||
| Singapore | 2020 | 20 | 27 | 31 | 11 | 0 | 41.2 | 0 | <0.001 | 55.3 | 0.0 | ||||
| Singapore | 2021 | 50 | 5 | 12 | 14 | 0 | 45 | 0 | <0.001 | 58.1 | 0.0 | ||||
| Thailand | 2020 | 25 | 33 | 50 | 25 | 0 | 28.3 | 0.7 | <0.001 | 44.2 | 0.0 | ||||
| Thailand | 2021 | 6 | 9 | 14 | 8 | 0 | 29.6 | 0 | <0.001 | 39.5 | 0.0 | ||||
| Vietnam | 2020 | 12 | 15 | 27 | 15 | 0 | 28.3 | 0 | <0.001 | 37.5 | 0.0 | ||||
| Vietnam | 2020 | 28 | 42 | 34 | 44 | 42 | 47 | 14 | 5 | 25.4 | 20.7 | 0.96 | 34.5 | 23.0 | 0.04 |
| Vietnam | 2021 | 12 | 1 | 15 | 2 | 27 | 4 | 15 | 3 | 28.3 | 22.1 | 0.003 | 37.5 | 25 | 0.03 |
Abbreviation: Lao PDR, Lao People's Democratic Republic.
FIGURE 1Seasonal (2020–2021) and average (2015–2019) influenza curves and peaks by epi week
Average proportion of surveillance specimens positive for influenza, by year
| Specimens tested | Proportion positive for influenza | |||||
|---|---|---|---|---|---|---|
| Country | 2015–2019 average | 2020 | Change (%) | 2015–2019 (Weeks 10–53) | 2020 (Weeks 10–53) |
|
| Bangladesh | 7104 | 5534 | −22.1 | 14.6 | 3.9 | <0.001 |
| Indonesia | 3556 | 1376 | −61.3 | 22.2 | 4.5 | <0.001 |
| India | 20,990 | 10,715 | −49.0 | 12 | 3.2 | <0.001 |
| Cambodia | 1332 | 1136 | −14.7 | 23.3 | 14.2 | 0.002 |
| Lao PDR | 4522 | 2505 | −44.6 | 14.3 | 3.2 | <0.001 |
| Malaysia | 4380 | 3161 | −27.8 | 9.9 | 1.2 | <0.001 |
| Singapore | 2628 | 3234 | 23.1 | 35.3 | 0.5 | <0.001 |
| Thailand | 3113 | 2981 | −4.2 | 26.1 | 2.8 | <0.001 |
| Vietnam | 2437 | 2029 | −16.7 | 22.1 | 4.6 | <0.001 |
Abbreviation: Lao PDR, Lao People's Democratic Republic.
Influenza viruses circulating in 2020 and 2021
| Circulating influenza viruses just before COVID‐19 pandemic (Week 1 2019 to Week 10 2020) | Circulating influenza viruses during the COVID‐19 pandemic (Weeks 10–52, 2020) | Circulating influenza viruses during the COVID‐19 pandemic (Weeks 1–26, 2021) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Country | Influenza peak during COVID 19 pandemic | % A (H1pdm09) | % A(H3) | % B Yam | % B Vic | Total number of positive samples | % A (H1pdm09) | % A (H3) | % B Yam | % B Vic | Total number of positive samples | % A (H1pdm09) | % A (H3) | % B Yam | % B Vic | Total number of positive samples |
| Bangladesh | Y | 22.1 | 33.4 | 4.2 | 39.7 | 1866 | 12.2 | 87.8 | 0.0 | 0.0 | 245.0 | 0.0 | 1.2 | 0.0 | 98.8 | 83.0 |
| Indonesia | Y | 48.5 | 23.8 | 2.7 | 24.9 | 811 | 1.6 | 98.4 | 0.0 | 0.0 | 128.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| India | N | 60.7 | 27.9 | 1.0 | 5.0 | 11,004 | 71.9 | 17.2 | 0.0 | 0.5 | 192.0 | 8.2 | 89.8 | 0.0 | 1.5 | 196.0 |
| Cambodia | Y | 46.6 | 27.0 | 0.3 | 2.3 | 365 | 31.5 | 57.6 | 0.0 | 10.9 | 92.0 | 0.0 | 0.0 | 0.0 | 100.0 | 1.0 |
| Lao PDR | Y | 27.5 | 25.8 | 1.0 | 27.5 | 596 | 0.8 | 99.2 | 0.0 | 0.0 | 123.0 | 0.8 | 99.2 | 0.0 | 0.0 | 123.0 |
| Malaysia | N | 34.7 | 14.1 | 0.0 | 0.4 | 1376 | 33.3 | 51.1 | 0.0 | 0.0 | 45.0 | 0.0 | 100.0 | 0.0 | 0.0 | 1.0 |
| Singapore | N | 51.2 | 18.9 | 1.9 | 25.6 | 1513 | 33.3 | 4.8 | 0.0 | 0.0 | 21.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Thailand | N | 28.8 | 24.4 | 0.7 | 42.9 | 1804 | 61.4 | 30.7 | 0.0 | 3.4 | 88.0 | 0.0 | 100.0 | 0.0 | 0.0 | 2.0 |
| Vietnam | Y | 53.2 | 4.5 | 2.6 | 14.6 | 378 | 0.0 | 100.0 | 0.0 | 0.0 | 123.0 | 0.0 | 100.0 | 0.0 | 0.0 | 39.0 |
Abbreviation: Lao PDR, Lao People's Democratic Republic.
Multivariate associations between non‐pharmaceutical measures and influenza transmission
| Multivariate associations between non‐pharmaceutical interventions* and presence (yes/no) of a seasonal influenza epidemic between January 2020 and June 2021, controlling for population density | Multivariate associations between non‐pharmaceutical interventions* and percent of respiratory specimens positive for influenza across 2020/21 influenza epidemics,** controlling for population density | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Model# | Variable | IRR |
| 95% CI | Model# | Variable | RPR |
| 95% CI |
| 1 | Oxford Stringency Index (OSI)** | 0.98 | 0.02 | 0.96, 1 | 12 | Oxford Stringency Index (OSI)*** | 0.97 | 0.1 | 0.93, 1.01 |
| 2 |
|
|
|
| 13 | School closings | 0.94 | 0.71 | 0.69, 1.29 |
| 3 | Workplace closures | 0.86 | 0.29 | 0.64, 1.14 | 14 | Workplace closures | 1.51 | 0.1 | 0.92, 2.48 |
| 4 | Canceling public events | 0.81 | 0.27 | 0.56, 1.17 | 15 |
|
|
|
|
| 5 | Restrictions on gatherings | 0.91 | 0.32 | 0.76, 1.09 | 16 | Restrictions on gatherings | 0.93 | 0.37 | 0.79, 1.09 |
| 6 | Closing public transport | 0.69 | 0.29 | 0.34, 1.38 | 17 | Closing public transport | 0.77 | 0.47 | 0.38, 1.57 |
| 7 | Stay at home orders | 0.69 | 0.13 | 0.42, 1.12 | 18 | Stay at home orders | 0.90 | 0.67 | 0.55, 1.47 |
| 8 | Restrictions on internal movements | 0.89 | 0.55 | 0.61, 1.3 | 19 |
|
|
|
|
| 9 | International travel restrictions | 0.73 | 0.47 | 0.32, 1.71 | 20 | International travel restrictions | 0.41 | 0.1 | 0.14, 1.19 |
| 10 | Public information campaigns | 1.00 | NA | NA | 21 | Public information campaigns | 0.00 | NA | NA |
| 11 | Mask mandates | 1.00 | 0.98 | 0.79, 1.27 | 22 | Mask mandates | 0.88 | 0.34 | 0.67, 1.15 |
| *measured 4 weeks prior to the typical start of the influenza epidemic**OSI is a composite measure of 23 individual COVID‐19 non‐pharmaceutical interventions | *measured 4 weeks prior to the typical start of the influenza epidemic** for countries with no epidemic, dates for the typical epidemic season were used***OSI is a composite measure of 23 individual COVID‐19 non‐pharmaceutical interventions | ||||||||
Abbreviations: CI, confidence interval; OSI, Oxford Stringency Index; RPR, relative proportion ratio.
Note: Bold indicates variables that had significant results in the multivariate analysis.